Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 74 Foreign Institutions (8.6%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
160 Million
(Quarterly Results - Jun 2025)
Net Profit:
26 Million
Pharmaceuticals & Biotechnology
ILS 1,312 Million ()
14.00
NA
0.03%
-0.26
10.68%
1.50






